Status:
COMPLETED
Role of Prophylactic Antibiotics in New Introducer PEG-Gastropexy
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Collaborating Sponsors:
Bethanien Krankenhaus gGmbH
Conditions:
Head and Neck Neoplasms
Wound Infection
Eligibility:
All Genders
16-88 years
Phase:
NA
Brief Summary
Peristomal infections are the commonest complications of PEG despite prophylactic antibiotics which may result in emergence of resistant micro-organisms like Methicillin resistant Staphylococcus aureu...
Detailed Description
BACKGROUND:PEG can be performed by pull, push or introducer technique, pull method is the one most commonly used worldwide. PEG site infection is clearly the commonest procedure related complication o...
Eligibility Criteria
Inclusion
- Patients having very tight stenotic malignant lesions of the upper GI tract (i.e. esophagus and or oropharynx) in whom routine pull PEG is not possible without dilatation/bougeinage of the UGI tract. The GI lumen in patients included in this study would have just sufficiently enough diameters to allow only the passage of thin (8.8 mm) endoscope.
Exclusion
- Allergies to Ceftriaxone antibiotics,
- Patients receiving systemic antibiotics,
- Any contraindications to PEG like, severe coagulation disorders, peritonitis, peritoneal carcinomatosis, burns or inability to achieve transillumination.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00375414
Start Date
October 1 2003
End Date
April 1 2007
Last Update
May 7 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine I, Division of Gastroenterology and Clinical Nutrition, Johann Wolfgang Goethe-University Hospital,
Frankfurt am Main, Germany, D60590